Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Read More
Company
Our TechnologyOur StoryOur TeamCareersContact Us
Solutions
For OncologistsFor Partners
Resources
All ResourcesNewsMedia CoveragePublicationsEnhancing NGS
Order a Report
Terms of Use | Cookie Policy | Privacy Policy
All Resources
Publications
Events
Media Coverage
News
Press ReleasesPartnershipsArticlesEnhancing NGS
Order a Report
Close Cookie Popup
We use cookies
We use cookies to enhance your browsing experience, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Learn more in our Cookie Policy.
Accept All Cookies
Reject All
Preferences
Close Cookie Preference Manager
Cookie settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Accept All Cookies
Save preferences
Made by Flinch 77
Oops! Something went wrong while submitting the form.
Cookies Preferences
May 7, 2025
Back to Media Coverage

Istvan Petak introduced Nabil Hafez as the new CEO of Genomate Health

May 7, 2025

...It is my great pleasure to introduce Nabil Hafez, to my friends and the world as the CEO of Genomate Health. I am thankful to Nabil for joining us and advancing Genomate to its next growth phase. - Dr. Istvan Petak

Other Media Coverage

See all
Selecting Targeted Cancer Therapies and Clinical Trials with Computational Reasoning
November 12, 2025
Read Article
Genomate Health Raises $2M, Enters US Market With Precision Oncology Clinical Decision Support Tool
May 13, 2025
Read Article
Video: Outsmarting Cancer with Computational Precision Oncology
August 5, 2025
Read Article

Other Resources

Events
Publications
Browse All
News
Back to Top
Award banner - genomeweb, best place to work 2025
Company
Our Technology
Our Story
Our Team
Careers
Oncompas Medicine
Solutions
For Oncologists
For Partners
Order a Report
Resources
Browse
Publications
News
Events
Enhancing NGS
Precision Care Pledge
The Genomate® Report can be used and clinically interpreted only by physicians or other qualified healthcare professionals. Genomate® is a clinical decision support software and is not intended to diagnose, treat, cure, prevent, or mitigate any condition. None of the statements contained herein have been evaluated by the U.S. Food and Drug Administration. Learn more.